v3.26.3
Net Loss per Share Applicable to Common Stockholders (Tables)
9 Months Ended
Sep. 30, 2026
Net Loss per Share Applicable to Common Stockholders  
Schedule of antidilutive securities were not included in the diluted net loss per share

The following securities were not included in the diluted net loss per share calculation because their effect was anti-dilutive as of the periods presented (in thousands):

​

​

​

​

​

​

​

​

For the nine months ended

​

​

September 30, 

​

  ​ ​ ​

2026

  ​ ​ ​

2025

Series C convertible preferred stock

​

15,940

​

20,454

Common stock options

​

291,030

​

317,268

Common stock warrants - equity classified

​

100,619

​

92,891

Convertible notes and accrued interest

​

263,846

 

198,307

Total

​

671,435

​

628,920

​